Correlation Between Reliance Industries and Biofil Chemicals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Reliance Industries and Biofil Chemicals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reliance Industries and Biofil Chemicals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reliance Industries Limited and Biofil Chemicals Pharmaceuticals, you can compare the effects of market volatilities on Reliance Industries and Biofil Chemicals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reliance Industries with a short position of Biofil Chemicals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reliance Industries and Biofil Chemicals.

Diversification Opportunities for Reliance Industries and Biofil Chemicals

0.58
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Reliance and Biofil is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Reliance Industries Limited and Biofil Chemicals Pharmaceutica in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biofil Chemicals Pha and Reliance Industries is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reliance Industries Limited are associated (or correlated) with Biofil Chemicals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biofil Chemicals Pha has no effect on the direction of Reliance Industries i.e., Reliance Industries and Biofil Chemicals go up and down completely randomly.

Pair Corralation between Reliance Industries and Biofil Chemicals

Assuming the 90 days trading horizon Reliance Industries Limited is expected to generate 3.2 times more return on investment than Biofil Chemicals. However, Reliance Industries is 3.2 times more volatile than Biofil Chemicals Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Biofil Chemicals Pharmaceuticals is currently generating about 0.04 per unit of risk. If you would invest  122,213  in Reliance Industries Limited on September 4, 2024 and sell it today you would earn a total of  10,117  from holding Reliance Industries Limited or generate 8.28% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Reliance Industries Limited  vs.  Biofil Chemicals Pharmaceutica

 Performance 
       Timeline  
Reliance Industries 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Reliance Industries Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Biofil Chemicals Pha 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Biofil Chemicals Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady technical indicators, Biofil Chemicals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Reliance Industries and Biofil Chemicals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Reliance Industries and Biofil Chemicals

The main advantage of trading using opposite Reliance Industries and Biofil Chemicals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reliance Industries position performs unexpectedly, Biofil Chemicals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biofil Chemicals will offset losses from the drop in Biofil Chemicals' long position.
The idea behind Reliance Industries Limited and Biofil Chemicals Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Commodity Directory
Find actively traded commodities issued by global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.